Issues of management of patients with post-stroke cognitive impairment

Abstract

Stroke is second to third most common cause of death in the population and the leading cause of disability. More than 12 million strokes are registered annually in the world. Cognitive impairments (CI) significantly contribute to the disability of patients after a stroke, which limit daily activities no less than movement disorders. The article presents data on the prevalence of post-stroke CI (PSCI), examines the issues of epidemiology, risk factors, the main clinical and pathogenetic data of disorders, the peculiarities of their diagnosis and treatment. The issues of the dipyridamole use for the prevention of stroke and in patients with PSCI are discussed.